Preventive Cardiovascular Nurses Association

PCNA Login



Forgot Password?

Increasing Awareness and Improving Management of Venous Thromboembolism
Through the Application of Accepted Evidence-Based Guidelines


CONTINUING EDUCATION
RN, NP: 2 CE Credits (includes 1 contact hour pharmacology)
Release Date: November 2009

COURSE OVERVIEW:
Deep vein thrombosis (DVT) and Pulmonary Embolism (PE) are collectively known as VTE. An estimated 300,000 new cases of VTE occur in the United States annually despite the existence of well-documented risk factors, preventive therapies and treatment regimens that are readily available in the form of evidence-based guidelines. This course provides an overview of VTE that includes: 1) how to perform a VTE risk assessment; 2) the use of non-pharmacological and pharmacological therapies for VTE prevention; and 3) a discussion of quality improvement strategies to improve health systems compliance with evidence-based guidelines.

EDUCATIONAL OBJECTIVES:
Upon completion of this program, participants will be able to:
  1. Describe the high prevalence of VTE and the impact VTE has on morbidity and mortality.
  2. List risk factors and high risk patient populations associated with VTE.
  3. Identify and apply consensus standards, performance measures and guidelines designed to improve the outcomes of patients at risk for VTE.
  4. Give examples of non-pharmacologic and pharmacologic treatments used in the prevention and management of VTE.

CE Course Outline

Step 1: Print Journal Supplement/Article (pdf)
Step 2: Take CE Exam
Step 3: Quick Evaluation
Step 4: Print CE Certificate


Tell A Friend...
about this continuing education opportunity! Simply enter the email address of up to 3 colleagues, friends or family members and we will email them information about this program.

Email Addresses:
My Name:
My Email:

AUTHORS:
Janet Long, MSN, ACNP, CLS, FAHA
Rhode Island Cardiology Center
Providence, RI
Biography
Carol M. Mason, ARNP, CLS, FAHA
LifeLink Healthcare Institute
Tampa, FL
Biography
Geno Merli Geno Merli, MD
Jefferson Medical College, Thomas Jefferson University Hospital
Philadelphia, PA
Biography
Jane-Nelson-Worel Jane Nelson Worel, MS, APRN-BC, APNP
Meriter Heart Hospital
Madison, WI
Biography

AUTHOR DISCLOSURES:
Carol Mason, ARNP, CLS, FAHA
Consultant/Advisory Board: Sanofi-aventis, Abbott Labs, Merck/Schering Plough
Speaker's Bureau: Merck/Schering Plough, Abbott Labs

Geno Merli, MD
Grant/Research Support: Bristol-Myers Squibb, Bayer, Sanofi-aventis
Scientific Consultant: Bristol-Myers Squibb, Bayer, Sanofi-aventis
Speaker's Bureau: Sanofi-aventis

Janet Long and Jane Nelson Worel have no commercial relationships to disclose.


AUDIENCE:
Nurses, nurse practitioners, and other healthcare professionals interested in the prevention and management of cardiovascular disease.

COST:
This online educational activity is offered free of charge.

PARTICIPATION IN THE ACTIVITY AND RECEIPT OF CERTIFICATE OF CREDIT:
View the program materials, complete the online evaluation at the end of the activity, and print your CE certificate.

SPONSOR/ACCREDITOR:
This activity is sponsored by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Academy of Nurse Practitioners (AANP) as an approved provider of nurse practitioner continuing education, provider number 030602. This program is accredited for 2 contact hours which includes 1 hour of pharmacology. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

GRANTOR:
This activity is presented by PCNA through an educational grant from Medavera, Inc.